Last reviewed · How we verify

NCT03840889: SPPH

Secondary Postpartum Hemorrhage

Status unknown Last updated 15 February 2019
What this trial tests

trial testing Data collection in Postpartum Hemorrhage in 80 participants. Status unknown.

Timeline
1 March 2019
Primary endpoint
31 December 2021
30 June 2022

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment80
Start date1 March 2019
Primary completion31 December 2021
Estimated completion30 June 2022
Sites10 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

Adults 12 to 55, female only, with Postpartum Hemorrhage or Maternal Morbidity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postpartum hemorrhage (PPH) remains one of the leading causes of maternal mortality and morbidity worldwide, including in France, where it accounts for approximately 20% of maternal mortality. Although numerous studies have examined immediate PPH, very few have explored secondary (also called late) PPH. Moreover, there are no guidelines in France for the management of secondary PPH. Its frequency appears to vary from 0.2% to 3.0% of deliveries. It is, however, difficult to estimate because only severe secondary PPH will lead to hospitalization and the rare publications concern single-center studies. The cause of these secondary hemorrhages is often unknown, due to the lack of routine uterine aspiration. Nonetheless, this aspiration is not always medically justified. The principal objective of this study is thus to establish the incidence of severe late PPH in the general population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Data collection

Trials testing the same drug.

Other recruiting trials for Postpartum Hemorrhage

Currently open trials in the same condition.

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03840889.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing